GKB Ophthalmics received a ₹8.82 crore demand notice related to a 2009 litigation. The company is challenging this in the High Court and plans a fresh writ petition.
GKB Ophthalmics Faces ₹8.82 Crore Demand Notice
₹8.82 crore demand | 10-day compliance period | High Court challenge underway
Reader Takeaway: Company is contesting a large financial demand, highlighting ongoing legal risks and management's defensive strategy.
What just happened
GKB Ophthalmics Ltd has received a 'Notice of Demand' from the Office of the Mamlatdar of Bardez Taluka, Mapusa, Goa, dated July 13, 2026. The demand amounts to ₹8.82 crore and requires compliance within 10 days of the notice date.
Why this matters
This notice is a significant financial obligation stemming from a long-standing litigation, Case No. 32/09, concerning the adjudication of a Charter of Demands. The award was initially passed by the Industrial Tribunal (Panjim-Goa) on May 25, 2021, and the company has been contesting it.
The backstory
The company has been challenging the tribunal's award in the Hon'ble High Court of Bombay at Goa via Writ Petition No. WP/358/2021. This new demand notice escalates the immediate financial risk.
What changes now
Following the receipt of the demand notice, GKB Ophthalmics, in consultation with legal counsel, is preparing to file a fresh writ petition before the Hon'ble High Court of Bombay. The company is seeking appropriate relief to contest the recovery.
Risks to watch
The primary risk is the potential financial impact if the High Court does not grant relief and the company is compelled to pay the ₹8.82 crore. The short compliance timeline adds pressure.
Peer comparison
Companies involved in protracted legal battles often face such financial demands. The outcome for GKB Ophthalmics will depend on the judiciary's view on the merits of their challenge.
Context metrics
The current demand of ₹8.82 crore is linked to a case initiated in 2009, with a tribunal award in 2021, and now a demand notice in 2026. This highlights the extended duration of such legal proceedings.
What to track next
Investors should closely monitor stock exchange filings for updates on the new writ petition filed by GKB Ophthalmics and any interim orders or stays granted by the High Court.